These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: [Serial changes in serum CA 19-9 levels in pancreatic cancer].
    Author: Saito K, Tajiri H, Yoshimori M, Hijikata A, Ohkura H, Nakamura K, Ozaki H.
    Journal: Gan No Rinsho; 1987 Aug; 33(9):1057-60. PubMed ID: 3476762.
    Abstract:
    Levels of a new carbohydrate antigen CA 19-9, which is a monosialoganglioside identified by a monoclonal antibody, were measured in 41 patients with pancreatic cancer and these serial changes were investigated. To provide a contrast, the serum CEA levels were compared with the serum CA 19-9 levels. As the result of this study, it was found that the serial changes of the serum levels of CA 19-9 were more correlative to the clinical course of these patients with pancreatic cancer than those of the serum CEA levels.
    [Abstract] [Full Text] [Related] [New Search]